Overcoming of Microenvironment Protection on Primary Chronic Lymphocytic Leukemia Cells after Treatment with BTK and MDM2 Pharmacological Inhibitors

In B-chronic lymphocytic leukemia (B-CLL), the interaction between leukemic cells and the microenvironment promotes tumor cell survival. The Bruton’s tyrosine kinase (BTK) inhibitor ibrutinib is one of the first-in-class molecules for the treatment of B-CLL patients; however, the emerging mechanisms...

Descripción completa

Detalles Bibliográficos
Autores principales: Rimondi, Erika, Melloni, Elisabetta, Romani, Arianna, Tisato, Veronica, Casciano, Fabio, Rigolin, Gian Matteo, Milani, Daniela, Celeghini, Claudio, Zauli, Giorgio, Secchiero, Paola, Voltan, Rebecca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8293193/
https://www.ncbi.nlm.nih.gov/pubmed/34287267
http://dx.doi.org/10.3390/curroncol28040223

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8293193/
https://www.ncbi.nlm.nih.gov/pubmed/34287267
http://dx.doi.org/10.3390/curroncol28040223

Ejemplares similares